Skip to main content
. 2017 Aug 29;19(11):1400–1408. doi: 10.1007/s12094-017-1742-y

Fig. 2.

Fig. 2

Cumulative-cardiovascular-event-risk during follow-up of testicular cancer patients depending on adjuvant therapy